PharmTech Drug Digest 11.20
News|Articles|May 9, 2016

FUJIFILM Diosynth Opens Bioprocess Lab Facility

FUJIFILM Diosynth Biotechnologies Opens New Laboratory Facility in Research Triangle Park, NC.

FUJIFILM Diosynth Biotechnologies U.S.A. marked the completion of a new three-story, 62,000-sq-ft facility in Research Triangle Park, NC, with a ribbon-cutting event on May 9, 2016 that was attended by members of the local government and biotech community.

The facility, the BioProcess Innovation Center, houses the company’s process and analytical research and development, process sciences, and stability groups. These groups focus on process invention, design and development, and process and product characterization for clients.

“The construction and completion of this building reflects the continued commitment of our organization to provide our clients with the infrastructure to efficiently and innovatively bring their products to the clinic and beyond for the benefit of their patients,” said Steve Bagshaw, CEO, FUJIFILM Diosynth Biotechnologies in a press statement.

Source: FUJIFILM Diosynth Biotechnologies U.S.A.

 


Related to this article

Are Your Supplier Selection and Oversight Processes Robust Enough?
Despite best efforts to ensure a contract organization is following GMPs, a warning letter is issued by the FDA. Susan J. Schniepp, distinguished fellow at Nelson Labs, and Siegfried Schmitt, PhD, vice president, Technical at Parexel, provide advice for create a robust supplier selection and oversight system.
white pill capsule isolated on white background | Image Credit: ©F16-ISO100 -stock.adobe.com
PharmTech spoke with Chiara Bergerone, deputy CEO of Roquette’s Health & Pharma Solutions Business, about the company’s hydroxypropyl methylcellulose (HPMC) capsule, which was previewed at CPHI Milan 2026 in October.
Transitioning mRNA from R&D to GMP
Marco Pupo, PhD, innovation and development coordinator at Anemocyte, discusses the R&D-to-GMP transition and the changing shape of mRNA manufacturing facilities.